Human Immunome Project Inc

Analysis

Human Immunome Project Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in February 2015, 11 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Human Immunome Project Inc reported income of $3.0m and spending of $3.2m, spending 105% of what it took in. Across the 4 years on record, from December 2019 to December 2023, income fell from $4.4m to $3.0m (-31%), an average of -12% a year. The sharpest change came in the year to December 2022, when income rose by 50%. Over the whole period it spent 116% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Human Immunome Project Inc sits at the 75th percentile: it is larger than about 75% of them. Against every charity in United States with reported income it ranks in the 89th percentile, and in the 86th percentile within NY. Charities of a similar size with the same main cause include Magnificat Houses Inc ($3.0m), Healing Hands Health Center Inc ($3.0m) and Drogadictos Anonimos USA Inc ($3.0m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $666k (21% of expenses). Other salaries and wages came to $411k. At year end it held assets of $2.9m against liabilities of $1.0m, net assets of $1.9m. It reported 9 employees.